A
Asociacion Civil Selva Amazonica | Iquitos, Peru
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Emtricitabine
JNJ-64281802
Lenacapavir
Tenofovir Disoproxil Fumarate
Mebendazole
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
2 of 8 total trials
The purpose of this study is to evaluate the prophylactic effect of JNJ-64281802 with respect to the prevention of laboratory-confirmed dengue virus...
Enrolling
Dengue
Drug: Placebo
Drug: JNJ-64281802
The goal of this clinical study is to test how well the study drug, lenacapavir (LEN), works in preventing the risk of HIV.
Active, not recruiting
Pre-Exposure Prophylaxis of HIV Infection
Drug: PTM F/TDF
Drug: Placebo SC LEN
Trial sponsors
A
H
Clinical trials
Research sites
Resources
Legal
© Copyright 2024 Veeva Systems